Catalyst Wire Dossier Catalyst Wire Dossier

Cannabidiol Oral Solution (GWP42003-P, CBD-OS)

cannabidiol · Jazz Pharmaceuticals
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Cannabidiol Oral Solution (GWP42003-P, CBD-OS), covering 2021-12-29 to 2022-08-08. Get the full timeline:

Most recent: Clinical Trial Update: A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome [Phase 3]

See pricing